SkyCell AG Soars with $53 Million Raised to Revolutionize Pharmaceutical Logistics

SkyCell AG, the innovative Swiss company specializing in temperature-controlled hybrid containers for pharmaceutical logistics, has successfully raised $53 million in funding.

This significant financial boost will further propel the company's mission to revolutionize global pharmaceutical supply chains through its cutting-edge technology and commitment to sustainability.

With an impressive track record of reducing temperature excursions to less than 0.05% and slashing CO2 emissions, SkyCell's solutions have gained recognition from top pharma firms and airlines.

The newly acquired funds will enable SkyCell to expand its operations, enhance its data-driven supply chain optimization system, SkyMind, and continue driving positive change in the industry.

By offering reusable containers that significantly decrease CO2 pollution and landfill waste, SkyCell remains dedicated to fostering a greener and more efficient pharma logistics landscape.

Join SkyCell on their transformative journey towards a safer, more sustainable future for the pharmaceutical industry.